Lymphocytic Choriomeningitis Virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses

Journal of Neuroimmunology

Volumn 194, Issue 1-2, 2008, Pages 70-82

  Zhou, Shenghua ^a   Halle, Annett ^a   Kurt Jones, Evelyn A ^a   Cerny, Anna M ^a   Porpiglia, Ermelinda ^a   Rogers, Michael ^a   Golenbock, Douglas T ^a   Finberg, Robert W ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CNS glial cells; Lymphocytic Choriomeningitis Virus (LCMV); Toll like receptors

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA CELL; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIRUS MENINGITIS;

ANIMALS; ASTROCYTES; CHEMOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MYELIN PROTEINS; MYELOID DIFFERENTIATION FACTOR 88; PROTEOLIPIDS; SPECIFIC PATHOGEN-FREE ORGANISMS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 39849106737     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.11.018     Document Type: Article

References (39)

1. Allan J.E., Dixon J.E., and Doherty P.C. Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr. Top. Microbiol. Immunol. 134 (1987) 131-143
2. Ambrosini E., Remoli M.E., Giacomini E., Rosicarelli B., Serafini B., Lande R., Aloisi F., and Coccia E.M. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64 (2005) 706-715
3. Andersen I.H., Marker O., and Thomsen A.R. Breakdown of blood-brain barrier function in the murine lymphocytic choriomeningitis virus infection mediated by virus-specific CD8+ T cells. J. Neuroimmunol. 31 (1991) 155-163
4. Asensio V.C., and Campbell I.L. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71 (1997) 7832-7840
5. Bajetto A., Bonavia R., Barbero S., and Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82 (2002) 1311-1329
6. Battegay M., Cooper S., Althage A., Banziger J., Hengartner H., and Zinkernagel R.M. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates. J. Virol. Methods 33 (1991) 191-198
7. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., and Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27 (1990) 229-237
8. Bonthius D.J., Mahoney J., Buchmeier M.J., Karacay B., and Taggard D. Critical role for glial cells in the propagation and spread of lymphocytic choriomeningitis virus in the developing rat brain. J. Virol. 76 (2002) 6618-6635
9. Bowman C.C., Rasley A., Tranguch S.L., and Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43 (2003) 281-291
10. Campbell I.L., Hobbs M.V., Kemper P., and Oldstone M.B. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 152 (1994) 716-723
11. Clarke J.N., Lake J.A., Burrell C.J., Wesselingh S.L., Gorry P.R., and Li P. Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes. Virology 348 (2006) 141-155
12. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., and Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77 (2003) 4588-4596
13. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., and Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12 (2006) 1203-1207
14. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
15. Ebert S., Gerber J., Bader S., Muhlhauser F., Brechtel K., Mitchell T.J., and Nau R. Dose-dependent activation of microglial cells by toll-like receptor agonists alone and in combination. J. Neuroimmunol. 159 (2005) 87-96
16. Esen N., and Kielian T. Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns. J. Immunol. 176 (2006) 6802-6811
17. Farina C., Krumbholz M., Giese T., Hartmann G., Aloisi F., and Meinl E. Preferential expression and function of toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159 (2005) 12-19
18. Finberg R.W., and Kurt-Jones E.A. Viruses and toll-like receptors. Microbes. Infect. 6 (2004) 1356-1360
19. Frei K., Lins H., Schwerdel C., and Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152 (1994) 2720-2728
20. Frei K., Malipiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., and Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19 (1989) 689-694
21. Hertz L., McFarlin D.E., and Waksman B.H. Astrocytes: auxiliary cells for immune responses in the central nervous system?. Immunol. Today 11 (1990) 265-268
22. Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., and Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175 (2005) 4320-4330
23. Kamperschroer C., and Quinn D.G. The role of proinflammatory cytokines in wasting disease during lymphocytic choriomeningitis virus infection. J. Immunol. 169 (2002) 340-349
24. Kawai T., and Akira S. Antiviral signaling through pattern recognition receptors. J. Biochem. (Tokyo) 141 (2007) 137-145
25. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., Harris N.L., Junt T., Odermatt B., Clavien P.A., Pircher H., Akira S., Hengartner H., and Zinkernagel R.M. Immunoprivileged status of the liver is controlled by toll-like receptor 3 signaling. J. Clin. Invest. 116 (2006) 2456-2463
26. Lehnardt S., Henneke P., Lien E., Kasper D.L., Volpe J.J., Bechmann I., Nitsch R., Weber J.R., Golenbock D.T., and Vartanian T. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J. Immunol. 177 (2006) 583-592
27. McKimmie C.S., and Fazakerley J.K. In response to pathogens, glial cells dynamically and differentially regulate toll-like receptor gene expression. J. Neuroimmunol. 169 (2005) 116-125
28. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1 (2001) 135-145
29. Oldstone M.B. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263 (2002) 83-117
30. Olson J.K., and Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173 (2004) 3916-3924
31. Palliser D., Ploegh H., and Boes M. Myeloid differentiation factor 88 is required for cross-priming in vivo. J. Immunol. 172 (2004) 3415-3421
32. Pasare C., and Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21 (2004) 733-741
33. Sandberg K., Kemper P., Stalder A., Zhang J., Hobbs M.V., Whitton J.L., and Campbell I.L. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta. J. Immunol. 153 (1994) 220-231
34. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2 (2001) 947-950
35. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 (2005) 1-14
36. Wacher C., Muller M., Hofer M.J., Getts D.R., Zabaras R., Ousman S.S., Terenzi F., Sen G.C., King N.J., and Campbell I.L. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81 (2007) 860-871
37. Ward S.G., Bacon K., and Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity 9 (1998) 1-11
38. Zhou S., Kurt-Jones E.A., Mandell L., Cerny A., Chan M., Golenbock D.T., and Finberg R.W. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35 (2005) 822-830
39. Zinkernagel R.M., Pfau C.J., Hengartner H., and Althage A. Susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes-a model for MHC/disease associations. Nature 316 (1985) 814-817